Stručni rad

Proposal of Croatian Society for Rheumatology for anti-TNF-α therapy in adult patients with spondyloarthritides

Đurđica Babić-Naglić ; Klinika za reumatske bolesti i rehabilitaciju Medicinskoga fakulteta Sveučilišta u Zagrebu, Klinički bolnički centar Zagreb, Zagreb, Hrvatska
Nadica Laktašić ; Klinika za reumatske bolesti i rehabilitaciju Medicinskoga fakulteta Sveučilišta u Zagrebu, Klinički bolnički centar Zagreb, Zagreb, Hrvatska
Zrinka Jajić ; Klinika za reumatologiju, fizikalnu medicinu i rehabilitaciju, Klinička bolnica “Sestre milosrdnice”, Zagreb, Hrvatska
Branimir Anić ; Zavod za kliničku imunologiju i reumatologiju, Klinika za unutarnje bolesti, Klinički bolnički centar Zagreb, Zagreb, Hrvatska
Jadranka Morović-Vergles ; Zavod za kliničku imunologiju i reumatologiju, Klinika za unutarnje bolesti, Klinička bolnica “Dubrava”, Zagreb, Hrvatska
Božidar Ćurković ; Klinika za reumatske bolesti i rehabilitaciju Medicinskoga fakulteta Sveučilišta u Zagrebu, Klinički bolnički centar Zagreb, Zagreb, Hrvatska

Sažetak

Spondyloarthritides (SpA) as a group are one of the most common rheumatic disorders with a predominant affection of the spine. Conventinal disease modifying anti­rheumatic drugs which are effective in rheumatoid arthritis have poor effect on spinal inflammation. Today there
is confirmed efficacy of biologics in spondylitis. This therapy is expensive and potentially hazaradous. Croatian Society for Rheumatology set up recommendations for the use of TNF-α blockers in SpA. There are several important points to be considered before their use: diagnosis of Spa, duration and disease activity, previous therapy and it’s efficacy, application and efficacy of biologics,
contraindications and safety preacutions and finally a decision for continuous tretament with biologics.

Ključne riječi

spondyloarthritides; anti-TNF-α therapy; recomendations

Hrčak ID:

125392

URI

https://hrcak.srce.hr/125392

Datum izdavanja:

1.7.2007.

Podaci na drugim jezicima: hrvatski

Posjeta: 1.617 *